Oral topiramate effective for alcoholism

Journal of Family Practice

Volumn 52, Issue 9, 2003, Pages 682-687

  Anderson, Noble ^a   Oliver, M Norman ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; PLACEBO; TOPIRAMATE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG DEPENDENCE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; STATISTICAL SIGNIFICANCE; WITHDRAWAL SYNDROME;

EID: 0242456954     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (2)

1. Malcolm R, Myrick H, Roberts J, Wang W, Anton RF, Ballenger JC. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med 2002; 17:349-355.
2. Moak DH, Anton RF, Latham PK. Further validation of the Obsessive-Compulsive Drinking Scale (OCDS). Relationship to alcoholism severity. Am J Addict 1998; 7:14-23.